H.C. Wainwright Reiterates Neutral Rating on Inhibikase Therapeutics Inc (IKT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq rallies as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: IKT) | Delayed: 1.48 -0.06 (3.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.54 | 52 Week High | $ | |||
| Open | $1.57 | 52 Week Low | $ | |||
| Day High | $1.59 | P/E | N/A | |||
| Day Low | $1.47 | EPS | $ | |||
| Volume | 330,487 | |||||
